# Wyeth is now a wholly owned subsidiary trials: 484 (2026)

ClinicalTrials.gov lists 484 trials with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Wyeth is now a wholly owned subsidiary of Pfizer: 484 rows for $24.20, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/wyeth-is-now-a-wholly-owned-subsidiary-of-pfizer

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 484
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 484, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 11, 2013 | NCT01788553 | Study Of Remission In Patients Treated For Generalized Anxiety Disorder | Wyeth is now a wholly owned subsidiary of Pfizer | Observational | Completed | Anxiety Disorders | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01788553) |
| February 11, 2013 | NCT01788449 | Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance | Wyeth is now a wholly owned subsidiary of Pfizer | Observational | Completed | Bacterial Infections | 335 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01788449) |
| March 9, 2011 | NCT01311349 | Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics | Wyeth is now a wholly owned subsidiary of Pfizer | Observational | Completed | Infection | 1,575 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01311349) |
| December 29, 2010 | NCT01268124 | Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Schizophrenia | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01268124) |
| March 4, 2010 | NCT01080365 | Study Comparing Two Different Tablet Formulations Of Bosutinib Under Fed Conditions | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01080365) |
| February 4, 2010 | NCT01062256 | Study of Count Coughs in Subjects With Acute Upper Respiratory Tract Infections | Wyeth is now a wholly owned subsidiary of Pfizer | Not applicable | Completed | Infection | 265 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01062256) |
| January 15, 2010 | NCT01050218 | Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic... | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | Terminated | Diabetic Neuropathy, Painful | 237 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01050218) |
| January 11, 2010 | NCT01045993 | A Study To Evaluate Methods To Evaluate Back Pain | Wyeth is now a wholly owned subsidiary of Pfizer | Not applicable | Completed | Pain | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01045993) |
| October 27, 2009 | NCT01001936 | Study Evaluating SKI-606 in Subject With Solid Tumors | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Tumors | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01001936) |
| October 19, 2009 | NCT00997360 | Study of PKI-179 Administered Orally to Subjects With Solid Tumors | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Withdrawn | Advanced Malignant Solid Tumors | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00997360) |
| August 27, 2009 | NCT00966966 | Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00966966) |
| August 20, 2009 | NCT00962767 | Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st... | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | Completed | Leukemia, Myelocytic, Acute | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00962767) |
| August 17, 2009 | NCT00959881 | Study Evaluating The Coadministration of Begacestat And Donepezil | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy Subjects | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00959881) |
| August 6, 2009 | NCT00952913 | Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00952913) |
| August 6, 2009 | NCT00952367 | Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China | Wyeth is now a wholly owned subsidiary of Pfizer | Observational | Completed | Streptococcus Pneumoniae Infections | 3,641 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00952367) |
| July 8, 2009 | NCT00934674 | Study Comparing Two Different Tablet Formulations Of Bosutinib | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00934674) |
| June 29, 2009 | NCT00929643 | Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections | Wyeth is now a wholly owned subsidiary of Pfizer | Observational | Completed | Complicated Intra-Abdominal Infection | 203 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00929643) |
| June 26, 2009 | NCT00928551 | Comparative Formulation Study of Vabicaserin | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy Subjects | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00928551) |
| June 25, 2009 | NCT00927992 | Study Evaluating Liver Transplantation in Haemophilia Patients in Spain | Wyeth is now a wholly owned subsidiary of Pfizer | Observational | Completed | Hemophilia, Hemophilia B | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00927992) |
| June 5, 2009 | NCT00914888 | Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | Withdrawn | Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00914888) |
| June 4, 2009 | NCT00914121 | Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart) | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy Subjects | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00914121) |
| June 4, 2009 | NCT00913406 | Effect of Lutein in S-26 Gold On Growth And Safety | Wyeth is now a wholly owned subsidiary of Pfizer | Not applicable | Completed | Healthy | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00913406) |
| June 2, 2009 | NCT00911573 | Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To... | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 | Withdrawn | Skin Diseases, Infection | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00911573) |
| May 28, 2009 | NCT00909688 | Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00909688) |
| May 21, 2009 | NCT00906191 | Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Alzheimer Disease | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00906191) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 164 |
| Phase 1/2 | 5 |
| Phase 2 | 42 |
| Phase 2/3 | 3 |
| Phase 3 | 126 |
| Phase 4 | 70 |
| Not applicable | 11 |
| Observational | 63 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 424 |
| Terminated | 47 |
| Withdrawn | 13 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Alzheimer Disease | 32 |
| Depressive Disorder, Major | 27 |
| Arthritis, Rheumatoid | 25 |
| Depression | 23 |
| Schizophrenia | 17 |
| Pneumococcal Infections | 15 |
| Bacterial Infections | 15 |
| Spondylitis, Ankylosing | 14 |
| Hemophilia A | 12 |
| Hemophilia B | 11 |
| Renal Insufficiency | 10 |
| Neoplasms | 10 |
| Gastroesophageal Reflux | 8 |
| Infections | 8 |
| Arthritis, Psoriatic | 8 |
| Arthritis | 7 |
| Graft vs Host Disease | 7 |
| Pain | 6 |
| Leukemia | 6 |
| Psoriasis | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Depressive Disorder | 6 |
| Anxiety Disorders | 6 |
| Breast Neoplasms | 6 |
| Osteoarthritis | 5 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Clothing companies in the United States](https://specstream.ai/data/businesses/clothing-companies/united-states)
- [Computer wholesalers in the United States](https://specstream.ai/data/businesses/computer-wholesalers/united-states)
- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Dental hygiene clinics in the United States](https://specstream.ai/data/businesses/dental-hygiene-clinics/united-states)
- [Document shredding companies in the United States](https://specstream.ai/data/businesses/document-shredding-companies/united-states)
- [Eastern European restaurants in the United States](https://specstream.ai/data/businesses/eastern-european-restaurants/united-states)
